Strategy
Our strategic plans begin with an in-depth assessment of the disease category to identify unmet treatment needs. Those unmet needs are then aligned with clinical trial results, timing considerations, and available resources to develop a solid strategy that clearly defines a product’s role in the treatment of that disease.
- Global, local, and market-specific strategy development
- Therapeutic gap analyses and competitive publication assessments
- Coordination of global and local publication team activities
Content Development
Our writers are clinically-trained content experts who work well with external authors and understand the needs of your clinical audience. Our publications are accurate, relevant, and transparent.
- Abstracts, posters, manuscripts, and lecture material development
- Investigator briefs, clinical study reports, and product monographs
- Patient and caregiver educational materials
Compliance
Our global approach to Good Publication Policies (GPPs) helps you to maintain a uniformly high level of transparency and balance across all affiliates. Our GPPs incorporate three key components; compliance with government regulations, adherence to corporate policies and procedures, and sensitivity to regional cultural differences.
- Senior managers who are Certified Medical Publication Professionals (CMPP)
- Strict adherence to all major publishing guidelines, including ICMJE, CMSS, and GPP2